Performance Improvement 2011-2012. Is a Large-Scale Evaluation of the President's Cancer Panel Activities Feasible?


The President's Cancer Panel (PCP) identifies barriers to optimal development and implementation of all aspects of the National Cancer Program (NCP). A study was commissioned to determine whether a large-scale evaluation of Panel activities and progress related to Panel recommendations would be possible and informative. The study identified and collected explicit indicators and measures of the impact and degree of implementation of past recommendations. The goals of the study included identifying opportunities to improve activities of the Panel; documenting progress relative to Panel recommendations; and characterizing the Panel's role in the NCP progress.

It would be feasible to conduct a process evaluation of Panel activities and an outcome evaluation of intermediate outcomes such as implementation of Panel recommendations. Although short-term outcomes such as changes in awareness of and support for an issue might be evaluated, this type of analysis is resource-intensive and might not be informative. Direct links between the Panel and recommendation implementation activities might be drawn; however, there are limitations to the practicality and utility of carrying out a large-scale attribution evaluation. A more thorough process evaluation of Panel dissemination activities would identify opportunities to improve and expand current Panel dissemination activities to better reach and influence intended implementers and key stakeholders.

Report Title: President's Cancer Panel Evaluation Feasibility Study
Agency Sponsor: NIH, National Institutes of Health
Federal Contact: Rosanna Ng, 301-496-5367
Performer: NOVA Research Company
Record ID: 9387 (Report issued December 15, 2009)

View full report


"PerformanceImprovement2011-2012.pdf" (pdf, 701.44Kb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®